THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Clinical trials for THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) explained in plain language.
Never miss a new study
Get alerted when new THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) trials appear
Sign up with your email to follow new studies for THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Safety watch: tracking rare blood disorder treatment in real patients
Disease control Not yet recruitingThis study aims to monitor the long-term safety of Adzynma, a replacement enzyme therapy for people with congenital thrombotic thrombocytopenic purpura (cTTP), a rare inherited blood clotting disorder. Researchers will review medical records of about 50 patients who have already …
Matched conditions: THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Sponsor: Takeda • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Looking back at a lifesaving enzyme for rare blood disease
Disease control Not yet recruitingThis study looks back at medical records to understand how a manufactured enzyme therapy helped people with a rare, inherited blood disorder called congenital TTP. The therapy, called rADAMTS13, is designed to replace a missing enzyme to help prevent dangerous blood clots. Resear…
Matched conditions: THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Sponsor: Takeda • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC